Introduction
Lignans are naturally occurring secondary me tabolites formed by enzymatic dimerization of phenylpropanoid precursors (mostly cinnamyl alcohols such as coniferyl alcohol). The first link age is formed between the side chains C-2 o f both monomers. By introduction o f further linkages several types o f lignans may be produced (Fig. 1) . The biological significance of these com pounds is not yet fully clear. F or instance wounded conifers excret balsams containing lignans. Certain lignans inhibit the germination of seeds or are powerful ir ritants (e.g. podophyllotoxin) repelling potential predators [1] . Dibenzylbutanolide type lignans conjugated to glucuronic acid were also identified as urinary constituents in man; a relationship of these lignans and the function o f gonads/ovaries has been proposed [2] . Certain natural cyclolignanolide type com pounds, such as podophyllotoxin, act as spindle poisons inhibiting microtubule assembly [3] . On the other hand, the semisynthetic podophyllotoxin derivative, etoposide, which is clinically used as a cytostatic agent [4] , probably possesses another mechanism of action through which it inhibits cell poliferation: it has been shown to interfere with the activity of topoisomerase II [5] , E.g. the inhibi tory effect of etoposide on plaque form ation by Herpes simplex virus in cultured cells has been a t tributed to an impairment of function o f host cell topoisomerase II [6] . However, in contrast to podophyllotoxin which displays a considerable in vitro anti-Herpes simplex virus effect, etoposide was active only at very high concentrations [7] .
In a tropical climbing shrub, Ipomoea cairica (L.) SWEET (Convolvulaceae), we discovered two lignanolides [8] which we could isolate from the above-ground parts and characterize as (-)-arctigenin [9] and (-)-trachelogenin [10] . Here we re port that these 2,3-dibenzylbutanolide type com- pounds exhibit a strong anti-HIV activity in vitro, while a group of different types of lignans which has been included in these studies were without ef fect. Previously we determined that infection of H 9 cells with HIV-1 in vitro results in a transient decrease of D N A topoisomerase II activity (at day 1 -3 ), followed by a drastic increase at day 4 [11], Simultaneously, the production of HIV-1 strongly increased. The topoisomerase II represents a m ajor com ponent of the nuclear matrix [12, 13] . O ur studies presented in this report revealed that (-)-arctigenin and (-)-trachelogenin efficiently in hibit both nuclear and nuclear matrix-associated topoisomerase II activity from uninfected and HIV-infected cells. Plasmid pBR322 D N A was isolated from the bacteria by lysis with SDS and by CsCl equilib rium gradient sedimentation in the presence of ethidium bromide, as described [16] .
M aterials and Methods

Compounds
Cell growth inhibition studies
L5178y mouse lymphoma cells were grown in Eagle's minimum essential medium, supplemented with 10% horse serum in roller tube cultures [17, 18] . Dose response experiments were perform ed as described [18] . The cell concentration was deter mined electronically (Cytocomp C ounter, model Michaelis). The ED 50 (inhibition concentration, causing 50% inhibition of cell growth) was esti mated by logit regression [19] .
H T L V-IIIB and H 9 cells
The culture conditions of the uninfected and HIV-1 (strain HTLV-III B)-infected H 9 cells (hu man T-cell line, clone 9) [20] and of the Jurkat cell system [21] were as described. H 9 cells were m ain tained in RPM I 1640 medium containing 20% fetal calf serum. H 9 cells (5 x 105 cells/ml) were in fected with 1.6 x 106 HTLV-III B particles, ob tained from culture supernatants o f virus produc ing H 9 cells [22] , Cultivation was perform ed for 4 days in the absence or presence of the com pounds. The com pounds were dissolved in dimethylsulfoxide at a stock concentration o f 2 m M ; they were added 5 h after addition o f the virus (= day 0) to the uninfected or infected cultures. The final concentration of dimethylsulfoxide was less than 0.1%.
The percentage o f cells expressing HIV-1 p l7 and p24 gag protein was determined by indirect immunofluorescence microscopy [23] ; under the conditions used the reactivity of the m onoclonal antibodies used with untreated H IV -1-infected H 9 cells was 37% (anti-p 17) and 44% (anti-p24), re spectively. As a measure for virus production, the reverse transcriptase activity was determined in the culture supernatants, as described [23, 24] . In the supernatant from untreated cells, infected for 4 days with HIV-1, the activity of this enzyme was 5.7 x 105 cpm/ml culture fluid. This value and the number of p i 7-and p24-positive cells in the un treated H IV -1-infected control cultures were set at 100%.
The syncytium-induction assay was performed as described [25] . HTLV-III B-infected H 9 cells (1 x 105 cells) incubated for 4 days in the absence or presence of com pound were mixed with 1 x 105 uninfected Jurkat cells in a final volume of 100 |il.
Preparation o f nuclei and nuclear matrix
Nuclei were isolated from uninfected and HIV-1-infected H 9 cells by the method of Blobel and Pot ter [26] , except that 1 m M phenylmethanesulfonyl fluoride and 5 m M 2-mercaptoethanol were added to all the buffers used. Nuclear matrices were pre pared as described previously [27, 28] ; 0.12 mg of matrix protein was determined to correspond to 106 nuclei. The nuclei and nuclear matrices were inspected electron microscopically; no differences between these substructures from uninfected and H IV -1-infected cells were observed [29, 30] .
Nuclear extracts for determ ination o f nuclear DNA topoisomerase II activity were prepared by treatment of nuclei with 30 m M Tris-HCl (pH 7.9), 350 m M NaCl, 1 m M EDTA, 0.5 m M dithiothreitol, 10 m M sodium metabisulfite (pH 7.0), 10% glyc erol, 1 m M phenylmethanesulfonyl fluoride, as described [31, 32] , DNA topoisomerase II assay DNA topoisomerase II activity was determined by measuring the relaxation of supercoiled plas mid pBR322 DNA in the presence of ATP, essen tially as described [33] . The standard reaction mix ture contained in a final volume of 40 jil, 0.6 |ig of negatively supercoiled circular pBR322 DNA (containing <10% nicked circles) and 1 m M ATP in 10 m M Tris-HCl (pH 8.0), 5 m M MgCl2, 50 m M KC1, 50 m M NaCl, 15 (ig/ml of bovine serum albu min. Either nuclear extract (5 j j .1 ) from 7 x 104 nu clei or 8 |ig (with respect to protein) of nuclear m a trix preparation were added to the standard assay. After incubation for 0 -3 0 min at 30 C in the ab sence or presence of com pound, reactions were ter-minated as described previously [13] . The reaction products were analyzed by electrophoresis in 1% agarose gels followed by ethidium bromide stain ing. DNA bands visible under UV light were pho tographed using a Polaroid 665 film. The percent age of DNA relaxed was quantitated by scanning densitometry as previously described [13, 32, 33] .
Protein was determined as described by Lowry et al. [34] using bovine serum albumin as a stand ard.
Results and Discussion
As shown in Table I , the 2,3-dibenzylbutanolides (-)-arctigenin and its natural 2-hydroxy de rivative (-)-trachelogenin are potent anti-HIV agents in vitro. Using the H 9/H TLV -IIIB system, (-)-arctigenin at the low concentration of 0.1 jag/ ml (0.27 |i m ) was found to reduce the expression of viral p l7 and p24 proteins by 6 0-70% ; (-)-trachelogenin at 0.2 |ig/ml (0.52 |j m ) inhibited the ex pression of these proteins by 6 0 -7 0 % (Table I) . At the same concentrations, the reverse transcript ase activity in the culture supernatants (as a meas ure o f production of HIV-1) was reduced to 69% and 57%, respectively. At higher concentrations ( > 1 -2 |i m ) , the com pounds are toxic for the cells. (-)-A rctigenin and (-)-trachelogenin efficiently abolished cell fusion with Jurkat cells (by 85%) at a concentration of 0.2 |ig/ml (0.54 (jm) and 0.3 |ig/ ml (0.77 |iM ), respectively.
A series of other types of lignans, most of them closely related to arctigenin and trechelogenin, do not exhibit any anti-HIV activity (Table I) . Even arctiin, the ß-D-glucoside of (-)-arctigenin, was in active. From these results we conclude that only very small variations in the structure of the mole cule lead to a complete loss o f anti-HIV activity. As arctiin was inactive, a free phenolic hydroxyl at C-4 o f the substituted benzyl moiety at C-2 might be im portant for the anti-HIV activity of (-)-arctigenin and (-)-trachelogenin. The lack of activity of the butyram ide derivative indicates that a lac tone ring might be necessary, particularly because (-)-cubebin, which can be considered as a simple reduction product of the corresponding lactone, was also inactive. Finally, it is remarkable that the cyclolignanolide type com pound podophyllotoxin displays no activity. From this fact we assume that the additional ring closure between the side chain -2-(4-hydroxy-3-m ethoxybenzyl)-3-(3,4-dimethoxybenzyl) of the second phenylpropanoid m onom er and the aromatic moiety of the first m onom er is accom pa nied by a complete loss of activity. However, addi tional studies including further derivatives with different com binations of structural variations will be necessary to corroborate these assumptions.
The results from the cell growth inhibition stud ies of the different lignan type com pounds in the L5178y mouse lymphoma cell system are sum m a rized in Table II . O ur results indicate that the cyto static activity and anti-HIV activity of the lignans are based on different mechanisms of action: podophyllotoxin is a strong cytostatic agent (Table II) , while it was found to be inactive against -2-(4-hydroxy-3-methoxybenzyl)-3-(3,4-dimethoxybenzyl) HIV (Table I) . Furthermore, (-)-arctigenin, (-)-trachelogenin and its 2,3-dibenzylbutyramide derivative showed remarkable and comparable cytostatic properties (Table II) ; however, only the first two compounds but not the butyramide dis played anti-HIV activity (Table I ).
Previously we determined that during the initial phase of infection (at day 1-3 ) of H 9 cells with HIV-1 in vitro nuclear DNA topoisomerase II ac tivity decreased and then, at day 4, strongly in creased [11] . The increase in topoisomerase II ac tivity coincided with the onset of virus production [11] . The underlying mechanism o f these altera tions in DNA topoisomerase II activity was found most likely to be a change in the phosphorylation state of the enzyme [11] . DNA topoisomerase II has been shown to be a phosphoprotein [31, 32, [35] [36] [37] , It is phosphorylated in vitro by casein ki nase II [35] , nuclear protein kinase N II [32] or pro tein kinase C [32, 36, 37] , Phosphorylation of the enzyme, resulting in an enhanced enzyme activity, has also been dem onstrated in vivo [31] . The phos phorylation state of the enzyme has been shown to be correlated with its DNA relaxing activity [31, 32, [35] [36] [37] . The lower level of topoisomerase II activity in the early phase of infection may be due to an impairment of the phosphatidylinositol/protein kinase C pathway, caused by com ponents of HIV-1 [38] , resulting in a reduced phosphoryla tion of nuclear matrix-associated D N A topoiso merase II and hence in an inhibition of this en zyme [39] . Inhibition of protein kinase C-mediated phosphorylation of D N A topoiso merase II has been demonstrated to result in an inhibition of HIV-1 production [11] .
In the following experiments, DNA topoiso merase II activity was determined in the nuclear matrix of H 9 cells, which contains a large portion of the type II enzyme activity, present in the nu cleus, but only a small am ount of nuclear topoiso merase I activity [12, 13, 32] , The measurements were perform ed using H 9 cells infected for 4 days by HI V -l, which contain a high level of DNA topo isomerase II activity [19] as well as in uninfected cells. (-)-A rctigenin and (-)-trachelogenin were found to cause a strong inhibition o f the matrixassociated enzyme activity (Fig. 2) . The conver sion rate o f the bacterial plasmid DNA after an in cubation period of 10 min from the fully super coiled circular form into the relaxed forms, meas ured with matrix preparation from uninfected cells, was 63% (Fig. 2 A) and that with matrix from infected cells, 81% (Fig. 2B) . In the presence of 1 |i m (-)-arctigenin or 1 |i m (-)-trachelogenin the DNA-relaxing activity of the enzyme from un- infected cells was reduced to 35% and 49%, re spectively (calculated after subtraction of the per centage am ount of used plasmid being not present in the fully supercoiled circular form). Interesting ly, a significantly stronger inhibition was found for topoisomerase II from HIV-infected cells; at the same concentrations the activity of the matrixassociated enzyme was decreased by the com pounds to 23% and 36%, respectively. An inhibi tion of topoisomerase II by (-)-arctigenin and (-)-trachelogenin was found not only for the m a trix-associated enzyme, but also for the enzyme in total nuclear extracts (Table III) . (-)-T rachelogenin was less efficient than (-)-arctigenin. Even at a concentration of 10 fiM , none o f the other test ed lignan type compounds displayed an inhibitory effect on topoisomerase II (Table III) . From our results showing that the activity of topoisomerase II correlates with HIV-1 produc tion [11] , inhibition of topoisomerase II by com pounds, such as (-)-arctigenin or (-)-trachelogenin, should be a promising strategy in treatm ent of HIV infection. Future studies must show whether the stronger inhibition of DNA-relaxing activity found in HIV-infected cells is due to a modifica tion of topoisomerase II or expression of a novel species of topoisomerase, as indicated in some studies [40] . The fact that the cytostatic activity and anti-HIV activity of lignans are apparently caused by different mechanisms of action of the com pounds offers the possibility to develop ana logs possessing a strong anti-HIV activity and a comparatively low cytotoxicity.
